Terry Vance insider trades
Open-market stock purchases and sales by Terry Vance, Director at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Mar 20, 2013.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -37%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 11, 2026 | ENTA Enanta Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- ENTA Enanta Pharmaceuticals Inc: 2 buys, 1 sale, last Mar 11, 2026